Recombinant R. sanguineus Evasin-1 Fc Chimera Protein, CF

Name: Recombinant R. sanguineus Evasin-1 Fc Chimera Protein, CF
Brand: rnd
SKU: 10016-EV

Catalog # 10016-EV

Datasheet / COA / SDS

Order Information

Bio-Techne Corporation

tel: (612) 379-2956

tel: (800) 343-7475 (free phone)

customercare.na@bio-techne.com

Shipping Information

$35 to United States

Products in stock will be shipped in 1-3 business days unless specified.

View Distributors

R&D Systems Guarantee

We offer a 100% guarantee on all our products.

Learn More »

Key Product Details

Source:	HEK293
Accession #:	P0C8E7.1
Structure / Form:	Disulfide-linked homodimer
Applications:	Bioactivity

View Full Technical Details for Recombinant R. sanguineus Evasin-1 Fc Chimera Protein, CF

Product Specifications

Source

Human embryonic kidney cell, HEK293-derived r. sanguineus Evasin-1 protein

Human IgG₁ (Met-Asp-Pro100 - Lys330)	IEGR	R. sanguineus Evasin-1 (Glu21-Asn114) Accession # P0C8E7.1
N-terminus		C-terminus

Purity

>90%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.

Endotoxin level

<0.10 EU per 1 μg of the protein by the LAL method.

N-terminal sequence Analysis

Met-Asp-Pro100

Predicted Molecular Mass

37 kDa

SDS-PAGE

40-61 kDa, reducing conditions

Activity

Measured by its ability to inhibit CCL3/MIP-1 alpha -induced chemotaxis of BaF3 mouse pro‑B cells transfected with human CCR5. The ED₅₀ for this effect is 0.2-1.2 μg/mL

Recombinant R. sanguineus Evasin-1 Fc Chimera Protein, CF Scientific Data Examples

	Recombinant R. sanguineus Evasin-1 Fc Chimera Protein Binding Activity Recombinant R. sanguineus Evasin-1 Fc Chimera (Catalog # 10016-EV) inhibits Recombinant Human CCL-3/MIP-1 alpha -induced chemotaxis of BaF3 mouse pro B cells transfected with human CCR5. The ED₅₀for this effect is 0.2-1.2 μg/mL.

Formulation, Preparation and Storage

Carrier Free

What does CF mean?

CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.

What formulation is right for me?

In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.

10016-EV

Formulation	Lyophilized from a 0.2 μm filtered solution in PBS.
Reconstitution	Reconstitute at 500 μg/mL in PBS.
Shipping	The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage:	12 months from date of receipt, ≤ -20 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, ≤ -20 °C under sterile conditions after reconstitution.

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

Volume (to add to vial)

Mass (in vial)

Desired Reconstitution Concentration

Background: Evasin-1

Evasin-1 is a highly selective chemokine-binding protein isolated from tick saliva. The cDNA of tick Evasin-1 encodes a 114 amino acid (aa) precursor, which include a 20 aa signal peptide and the 94 aa mature protein (1). Ticks are blood sucking parasites that secrete a wide variety of immunomodulatory proteins to evade the host immune response. The saliva isolated from Ticks has shown chemokine neutralization activity. A group of proteins contributing to this activity have been identified as chemokine-binding proteins (CHPBs) and named as Evasins (1-3). Evasin-1 shows high affinity binding to a very limited set of three highly homologous CC chemokines: CCL3, CCL4 and CCL18 (1). Since it is a small molecule, Evasin-1 may be therapeutically useful as novel anti-inflammatory agent.

Item	Value
References	Frauenschuh, A. et al. (2007) J. Biol. Chem. 282:27250. Deruaz, M. et al. (2008) J. Exp. Med. 205:2019. Deruaz, M. et al. (2013) FEBS J. 280:4876.
Long Name	Evasin-1
Alternate Names	Evasin-1

Citations

Currently there are no citations for Recombinant R. sanguineus Evasin-1 Fc Chimera Protein, CF.